SALT LAKE CITY, Oct. 29, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the closing of its previously announced...
Hence then, the article about co diagnostics inc announces closing of 7 0 million registered direct offering of common stock priced at the market under nasdaq rules was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules )
Also on site :
- Brendan Penny is ‘So Angry’ After Pal Robert Buckley’s Movie Premiere, But For the Funniest Reason (Exclusive)
- Beloved ’70s Singer-Songwriter, Who Influenced Kate Bush and Radiohead, Became an Icon Decades After His Tragic Death at 26
- Le moteur BC Engine de BC.GAME a dépassé les 10 millions de dollars de récompenses en six mois après son lancement.
